Sonoma Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:SNOA

Comments

Sonoma Pharmaceuticals Inc Earnings Estimates

SNOANASDAQ

Trade with Public

$2.55

0.124.94%

At close: Mar 20, 5:00 PM EST

$2.55

0.124.94%

Pre-Market: 4:24 AM EST

Overview NewsEarningsAnalyst Ratings Insider Trades Short Interest Stock Report

Sonoma Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:SNOA

In the most recent quarter (Q3), Sonoma Pharmaceuticals reported EPS of $-0.48, missing estimates of $-0.31 by 0.55%. Revenue came in at $4.35M, exceeding the estimate of $4.33M by 0.00%.

Sonoma Pharmaceuticals has missed EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Sonoma Pharmaceuticals has averaged an EPS surprise of 0.21% and a revenue surprise of 0.15%.

Earnings Date

Feb 10

EPS

$-0.480

Quarterly Revenue

$4.35M

Annual Revenue
(as of Dec 31)

$17.72M

Sonoma Pharmaceuticals Earnings History

Analyze the earnings history of Sonoma Pharmaceuticals using advanced sorting and filters.

Loading calendar...

Sonoma Pharmaceuticals (SNOA) Earnings Per Share

The chart below shows Sonoma Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.

Sonoma Pharmaceuticals (SNOA) Revenue

The chart below shows Sonoma Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Sonoma Pharmaceuticals (NASDAQ:SNOA) reporting earnings?

Sonoma Pharmaceuticals (SNOA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 10, 2026 for Q3.

What were the latest earnings per share (EPS) for Sonoma Pharmaceuticals (NASDAQ:SNOA)?

Sonoma Pharmaceuticals (SNOA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 10, 2026 for Q3 and the Actual EPS was $-0.48, which missed the estimate of $-0.31.

What were Sonoma Pharmaceuticals’s (NASDAQ:SNOA) revenues?

Sonoma Pharmaceuticals (SNOA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 10, 2026 for Q3 and the Actual Revenue was $4.35M, which beat the estimate of $4.33M.

People Also Watch

Iterum Therapeutics PLC

NASDAQ:ITRM

$0.17

1.73%

60 Degrees Pharmaceuticals Inc

NASDAQ:SXTP

$1.84

0.55%

Addex Therapeutics Ltd

NASDAQ:ADXN

$7.64

21.47%

Kiora Pharmaceuticals Inc

InMed Pharmaceuticals Inc

Sonoma Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:SNOA

In the most recent quarter (Q3), Sonoma Pharmaceuticals reported EPS of $-0.48, missing estimates of $-0.31 by 0.55%. Revenue came in at $4.35M, exceeding the estimate of $4.33M by 0.00%.

Sonoma Pharmaceuticals has missed EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Sonoma Pharmaceuticals has averaged an EPS surprise of 0.21% and a revenue surprise of 0.15%.

Earnings Date

Feb 10

EPS

$-0.480

Quarterly Revenue

$4.35M

Annual Revenue
(as of Dec 31)

$17.72M